Skip to main content
Clinical Trials/NCT04156165
NCT04156165
Completed
Not Applicable

BEEF The Effect of High vs. Moderate Protein Consumption on Human Health - With Beef as Major Source of Protein

University of Copenhagen1 site in 1 country110 target enrollmentNovember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Weight Loss
Sponsor
University of Copenhagen
Enrollment
110
Locations
1
Primary Endpoint
Body weight
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The study will be conducted as a parallel randomized controlled intervention trial, initiated by eight weeks rapid weight loss with one of two VLCDs, one week of reintroducing regular foods, and 12 weeks with one of two different ad libitum diets; in total 21 weeks. The study will be blinded for the statistician. Due to obvious different dietary intakes in the two diets, subjects cannot be blinded and neither the study personnel. As the study includes different dietary recommendations the registered clinical dietician advising the subjects cannot be blinded either.

In total 110 overweight and obese volunteers will be included.

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
December 31, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Arne Astrup

Professor. Dr.Med

University of Copenhagen

Eligibility Criteria

Inclusion Criteria

  • Healthy men or women
  • Age, 18-65 years
  • Overweight or grade I-II obesity (BMI 28-40.0 kg/m2)
  • Provided voluntary written informed consent
  • Exclusion Criteria (main:
  • Weight changes ± 5% in the last three months
  • Vegetarian, vegan
  • Pregnancy or lactation, pregnancy within the past 12 month or plans to become pregnant during the study
  • History or diagnosis of diabetes
  • History or diagnosis of heart, liver or kidney disease

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Body weight

Time Frame: up to week 21

The subjects will be instructed to stand in the middle of the platform of the scale with a straight neck and eyes looking straight ahead, whilst distributing their weight evenly on both feet. Two measurements are made when the scale has stabilized and both results are noted to the nearest 0.1 kg. The average of the two measurements is used in further analysis.

Secondary Outcomes

  • Blood pressure(Up to week 21)
  • Fecal samples(Up to week 21)
  • Waist circumference(Up to week 21)
  • Hip circumference(Up to week 21)
  • Body composition(up to week 21)
  • Resting metabolic rate(Up to week 21)
  • Endocrine disruptors(Up to week 21)
  • Glucose metabolism(up to week 21)
  • Inflammation(Up to week 21)
  • Height(Week 0)

Study Sites (1)

Loading locations...

Similar Trials